| Authors | Study designe |
No Fracture |
Open fracture | Fractures Classification Hawkins | Follow up | Talar Osteo-arthritis | Tibio-talar Arthritis | AVN | AVN with collapse | Non Union | Mal-union | Deep Infection | Wound Complication | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | |||||||||||||
| Bastos et al | Retrospective Study | 20 | 4/20 | 1 | 12 | 5 | 2 | 71m (14-159) |
10/14 (71,4%) |
13/18 (72.2%) |
4/20 (20%) |
2/20 (10%) | nr | nr | 2/20 (10%) | 4/20 (20%) |
| Schulze et al | Retrospective Study | 46 | nr | 10 | 18 | 17 | 1 | 6y (1-15) |
nr | nr | 8/46 (17.4%) | nr | 3/46 (6.5%) |
nr | 1/46 (21.7%) | nr |
| Fournier et al | Retrospective Study | 114 | 31/114 | 33 | 48 | 29 | 4 | 111m (7-351) | 84/110 (76%) |
84/110 (76%) | 39/114 (34%) | nr | nr | 37/114 (32%) | 6/114 (5%) | nr |
| Xue et al | Prospective Study | 28 | 0/28 | – | 19 | 9 | – | 25m (18-50) | 7/28 (25%) |
5/28 (18%) |
6/28 (21.4%) | nr | 1/28 (3.6%) | nr | 0 | 1.28 (3.6%) |
| Chateau et al | Retrospective Study | 23 | nr | – | 10 | 12 | 1 | 20m (6-52) |
1/23 (4,3%) |
2/23 (8.7%) | 4/23 (17.4%) | nr | 0/23 | 2/23 (8.6%) | 0/23 | 0/23 |
| Lindvall et al | Retrospective Study | 18 | 9/26 | – | 11 | 6 | 1 | 74m (48-113) | 13/26 (50%) |
13/26 (50%) |
13/26(50%) | nr | 3/26 (12%) |
5/26 (19%) | 2/26 (7.7%) | nr |
| Vallier et al | Retrospective Study | 102 | 24/102 | 4 | 68 | 25 | 5 | 36m (12-74) | 6/39 (15%) |
7/39 (18%) | 19/39 (49%) | 12/39 (31%) | 2/60 (3.3%) | nr | 3/60 (5%) | 2/60 (3.3%) |
| Vallier et al | Retrospective Study | 81 | 24/81 | 2 | 44 | 32 | 3 | 30.3m (11-120) | 25/65 (38%) |
19/65 (29%) | 16/ 65 (25%) |
9/65 (14%) | 2/65 (3%) |
2/65 (3%) |
1/77 (1.3%) | 1/77 (1.3%) |
| Sanders et al | Retrospective Study | 70 | 10/70 | – | 29 | 25 | 16 | 5.2y (2-10.5) |
78% | 40% | 5/44 (11%) | 2/44 (4.5%) | nr | 25/70 (36%) | nr | nr |
| Elgafy H | Retrospective Study | 27 | nr | 7 | 8 | 12 | – | 30m (24-65) | 18/27 (66,6%) |
5/27 (18.5%) | 7/27 (25.9%) | 1/27 (3.7%) | nr | nr | 2/27 (7.4%) | nr |
| Kai Wu | Retrospective Study | 29 | nr | 3 | 14 | 12 | – | 24m (18-36) | 10/29 (34,18%) |
10/29 (34.2%) |
9/29 (31%) | nr | 0/29 | nr | nr | 2/29 (6.89%) |
| Beltran et al | Retrospective Study | 24 | 4/24 | 4 | 15 | 4 | 1 | 44m (12-78) | 15/24 (63%) |
2/24 (8.3%) | 10/24 (42%) | 0/10 | 1/24 (4.2%) |
4/24 (17%) | 0/24 | 1/24 (4.2%) |
| Hui Liu et al | Retrospective Study | 21 | 1/21 | – | – | 22 | – | 29.6m (18-41) | 17/21 (80,9%) |
13/21 (32%) | 13/22 (59%) | 5/21 (24%) | 0/21 | 1/21 | nr | 1/21 (4.8%) |
| Ohi X et al | Retrospective Study | 10 | 4/10 | – | 3 | 5 | 2 | 7.5y | 87% | nr | 2/10 (20%) |
nr | 0/10 | 7/9 | nr | nr |
| Annappa R. et al | Retrospective Study | 20 | 7/20 | – | 11 | 7 | 2 | 28m | 9/20 (45%) |
2/20 (10%) |
6/20 (30%) |
2/20 (10%) |
1/20 (5%) |
1/20 (5%) |
nr | nr |
| Maceroli Ma et al | Retrospective study | 26 | 8/26 | – | 11 | 11 | 4 | 18,3m (18-42) |
7/26 (27%) |
6/26 (23%) |
7/26 (27%) |
4/27 (15%) |
3/26 (12%) |
0/20 | 1/26 (4%) |
nr |